首页> Rheumatology (Oxford, England)> Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study.

Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Stéphane,Zuily

第一单位： CHU de Nancy, Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, Vascular Medicine Division, Inserm, UMRS 1116, Nancy School of Medicine, Université de Lorraine, Nancy, France, s.zuily@chu-nancy.fr.

作者： Stéphane,Zuily ^[1] ; Bas,de Laat ^[2] ; Shirine,Mohamed ^[3] ; Hilde,Kelchtermans ^[4] ; Zakera,Shums ^[5] ; Roger,Albesa ^[5] ; Gary L,Norman ^[5] ; Claire,Lamboux-Matthieu ^[6] ; Anne-Christine,Rat ^[7] ; Jacques,Ninet ^[8] ; Nadine,Magy-Bertrand ^[9] ; Jean-Louis,Pasquali ^[10] ; Marc,Lambert ^[11] ; Bernard,Lorcerie ^[12] ; Pierre,Kaminsky ^[3] ; Francis,Guillemin ^[13] ; Véronique,Regnault ^[14] ; Denis,Wahl ^[15] ; TAC(I)T investigators

作者单位： CHU de Nancy, Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, Vascular Medicine Division, Inserm, UMRS 1116, Nancy School of Medicine, Université de Lorraine, Nancy, France, s.zuily@chu-nancy.fr. ^[1] Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Clinical Chemistry and Haematology, University Medical Centre Utrecht, Synapse BV, Maastricht, Department of Plasma Proteins/Blood coagulation, Sanquin Research, Amsterdam, The Netherlands. ^[2] Nancy School of Medicine, Université de Lorraine, Nancy, France, CHU de Nancy, Orphan Disease Unit, Nancy, France. ^[3] Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht. ^[4] Research and Development, Inova Diagnostics, San Diego, CA, USA. ^[5] CHU de Nancy, Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, Vascular Medicine Division. ^[6] Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Inserm, CIC-EC 1433, CHU de Nancy, Clinical Epidemiology and Evaluation Department, CHU de Nancy, Rheumatology Department, Nancy. ^[7] CHU de Lyon, Department of Internal Medicine, Lyon. ^[8] CHRU de Besançon, Internal Medicine Department, Besançon. ^[9] CHU de Strasbourg, Internal Medicine and Clinical Immunology Department, Strasbourg, F-67000. ^[10] CHRU de Lille, Department of Internal Medicine, Lille. ^[11] CHU de Dijon, Internal Medicine and Clinical Immunology Department, Dijon and. ^[12] Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Inserm, CIC-EC 1433, CHU de Nancy, Clinical Epidemiology and Evaluation Department. ^[13] Inserm, UMRS 1116, CHU de Nancy, Contrat d'interface, Nancy, France. ^[14] CHU de Nancy, Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, Vascular Medicine Division, Inserm, UMRS 1116, Nancy School of Medicine, Université de Lorraine, Nancy, France. ^[15]

关键词 anti-phosphatidylserine/prothrombin antibodies antiphospholipid syndrome global APS score systemic lupus erythematosus thrombosis